TM
TransMedics
TMDX · NASDAQ
$89.98 +6.24% (+$5.29)
1M +7.26%
Market Cap $3.01B
P/E Ratio 19.82x
Div. Yield -
ROE 32.97%
Bulios Fair Price
$92.26
2.5% upside
Current Price
$89.98
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TMDX is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
36 /100
Fair P/E 19.82x
PEG 0.04x
EV/EBITDA 28.35x
Growth
100 /100
Growing Rev. growth 86.42%
Book val. growth 36.17%
EPS growth N/A
Profitability
78 /100
Strong Gross margin 58.69%
FCF margin 11.82%
Net margin 22.69%
Quality
76 /100
Excellent ROIC 12.28%
Asset turnover 0.46x
ROE 32.97%
Debt
47 /100
Moderate Debt/Equity 1.67x
Net debt/EBITDA 3.29x
Current ratio 6.62x
Stability
6 /100
Unstable Beta 1.88x
Profitable years 2
Rev. volatility 61.32%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TMDX
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Waleed H. Hassanein
Employees
898
Headquarters
Andover
Upcoming events
04 NOV
Earnings
Upcoming earnings report